Concurrent Computer Corporation
Concurrent Launches Laguna(TM) Cache to Optimize Delivery of OTT Video and TVE Streaming
ATLANTA, June 15, 2017 (GLOBE NEWSWIRE) -- Concurrent, (NASDAQ:CCUR), a global leader in storage, protection, transformation, and delivery of visual media assets announced today the availability of LagunaTM Cache, a comprehensive multi-tiered caching solution that reduces latency and network utilization for video service providers to maximize the delivery of over-the-top (OTT) and TV Everywhere (TVE) video services to their customers.
As end-users consume video in massive amounts and in an increasing number of ways, service providers need flexible solutions in place to ensure that they can deliver content quickly and easily regardless of their customer's device or location. Designed to support the widest variety of content formats and streaming protocols, Laguna Cache optimally and intelligently caches content in private and open delivery networks. This enables OTT and TVE providers to distribute content for highly efficient delivery and to maximize the quality of experience for their customers.
Laguna Cache uses a new software-based services architecture, which offers flexible deployment options to meet increasingly changing customer requirements. Laguna runs on qualified commercial off-the-shelf (COTS) hardware, and can be licensed as a bundled hardware appliance, virtual machine, or container-based software package. This allows for on-premises hardware and software installation in the service provider's network or as part of a hybrid content delivery network (CDN).
Concurrent Laguna(TM) Cache provides intelligent caching for Live Streaming, Time-shift TV, cloud DVR, and Video On Demand services. Primary features include:
- Unified Cache and Streaming - Highly efficient delivery to RTSP QAM Set-Top Boxes and IP Devices leveraging Adaptive Bitrate (ABR) formats
- Edge and Intermediate Cache - Maximize network efficiency and optimize the end-user experience with support for multiple caching scenarios
- Hardware-assisted HTTPS - Support content encryption requirements without losing streaming density
- Sophisticated Request Routing Technology - Efficiently direct stream requests to the optimal caching server to maximize the viewer experience
- Flexible Software Deployment - Deploy Laguna as a bundled hardware appliance, virtual machine or container-based package
"Today it's critical for media companies to have the ability to deploy content across multiple screens in a time and device shifted world while maintaining a high QoE - all done cost effectively," said Mukul Krishna, Global Head of Digital Media at Frost & Sullivan. "By offering media companies the flexibility of building out a best of breed ecosystem with their choice of where and how to deploy multi-tiered caching, Concurrent has stepped up to the plate to help these media companies optimize delivery of digital content to customers for multiple use cases."
Concurrent (NASDAQ:CCUR) is a global software and solutions company that develops advanced applications focused on storing, protecting, transforming, and delivering high value media assets. We serve industries and customers that demand uncompromising performance, reliability and flexibility to gain a competitive edge, drive meaningful growth and confidently deliver best-in-class solutions that enrich the lives of millions of people around the world every day. Offices are located in North America, Europe and Asia. Visit www.concurrent.com for further information and follow us on Twitter: www.twitter.com/Concurrent_CCUR .
Certain statements made or incorporated by reference in this release may constitute "forward-looking statements" within the meaning of the federal securities laws. Statements regarding future events and developments and the company's future performance, including, but not limited to, management's expectations, beliefs, plans, estimates, or projections relating to the future, are forward-looking statements within the meaning of these laws. All forward-looking statements are subject to certain risks and uncertainties that could cause actual events to differ materially from those projected.
Important risk factors include, but are not limited to, our ability to reinvest the net proceeds from the sale of our Real-Time segment in a manner that we believe will generate an adequate return to our remaining business and the risk factors discussed in Concurrent's Form 10-K filed August 30, 2016 with the Securities and Exchange Commission ("SEC"), and in subsequent filings of periodic reports with the SEC. The risk factors discussed in the Form 10-K and subsequently filed periodic reports under the heading "Risk Factors" are specifically incorporated by reference in this press release. Forward-looking statements are based on current expectations and speak only as of the date of such statements. Concurrent undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of future events, new information, or otherwise.
All Concurrent product names and its logo are trademarks or registered trademarks of Concurrent while all other product names are trademarks or registered trademarks of their respective owners.
For more information, contact:
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
PRA Health Sciences24.5.2018 10:02 | pressemeddelelse
PRA Named International Clinical Research Company of the Year
Appian Corporation23.5.2018 13:31 | pressemeddelelse
Addiko Bank Implements Digital Banking Solutions on Appian
VITEC23.5.2018 10:01 | pressemeddelelse
VITEC to Showcase High-Quality, Low-Bandwidth Tactical Video Solutions at Eurosatory 2018
Jobindex A/S23.5.2018 08:33 | pressemeddelelse
1. kvartal 2018: Jobindex er kommet godt fra start
Gallene Sciences PVT. LTD22.5.2018 23:02 | pressemeddelelse
MyoGen: Leaders of an Anabolic Revolution
XBiotech, Inc22.5.2018 14:01 | pressemeddelelse
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum